Stability of two concentrations of tiagabine in an extemporaneously compounded suspension. 2003

Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
Texas Tech University Health Sciences, Center School of Pharmacy.

The short-term stability of two different concentrations of extemporaneously compounded tiagabine suspensions was studied. Six bottles each of 6-mg/mL and 2-mg/mL suspensions were compounded using commercially available 16-mg tiagabine tablets in a 1:1 mixture of Ora-Sweet and Ora-Plus. For each concentration, three bottles were stored in the dark in a stability chamber at 23 to 25 deg C, and three were stored in the dark in a refrigerator at 3 to 5 deg C, for 61 days. The stability of tiagabine in each of the concentrations and environmental conditions was determined after preparation and at 7, 14, 28, 42, and 61 days by means of a high-performance liquid chromatographic method, which involved a reverse-phase column, a gradient mobile phase containing acetonitrile and aqueous phosphoric acid at a flow rate of 2.75mL/minute. Detection was carried out by an ultravioldet spetrophotometer at 254 nm. The drug tiagabine, the internal standard (propylparaben) and degradant eluted at 8.4, 8.6, and 9.9 minutes, respectively. The high-performance liquid chromatographic validation involved limit of detection, limit of quantitation, accuracy and precision and interday and intraday variation. There was no appearance of degradation products in eiher concentration at any time. The suspensions stored at 23 to 25 deg C became slightly discolord after day 30 , turning slightly gray from blue. However, this change could not be attributed to tiagabine degradation. The refrigerated suspensions were found to be stable (retention of 90% potency) up to 40 days. The 6-mg/mL suspensions were stable up to the study period of 61 days; however, the 2-mg/mL suspension at 3 to 5 deg C showed a potency of 87.7% on day 61 of the study. Extemporaneously compounded liquid oral preparations of tiagabine 6mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet were stable for 61 days at 23 to 25 deg C and 3 to 5 deg C. The extemporaneously compounded liquid oral preparations of tiagabine 2mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet were stable for 61 days at 23 to 25 deg C and for 40 days at 3 to 5 deg C.

UI MeSH Term Description Entries

Related Publications

Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
January 1994, Clinical therapeutics,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
January 2005, International journal of pharmaceutical compounding,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
March 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
May 2016, Hospital pharmacy,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
June 1992, American journal of hospital pharmacy,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
June 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
February 2016, The Annals of pharmacotherapy,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
February 2001, Journal of clinical pharmacy and therapeutics,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
February 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Mark R Haase, and Mansoor A Khan, and Jeremiah Bonilla
October 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!